Your browser doesn't support javascript.
loading
Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults.
Gangatharan, Shane A; Maganti, Manjula; Kuruvilla, John G; Kukreti, Vishal; Tiedemann, Rodger E; Gospodarowicz, Mary K; Hodgson, David C; Sun, Alex; Tsang, Richard W; Pintilie, Melania; Crump, Michael.
Afiliação
  • Gangatharan SA; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Maganti M; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kuruvilla JG; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kukreti V; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Tiedemann RE; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Gospodarowicz MK; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Hodgson DC; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Sun A; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Tsang RW; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Pintilie M; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Crump M; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Br J Haematol ; 170(3): 384-90, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25904266
ABSTRACT
Follicular lymphoma (FL) in young adults (YA, <40 years old) is uncommon, and the clinical characteristics and outcomes of this group are not well defined. We conducted a retrospective database review of 427 patients with newly diagnosed FL aged 65 years or less registered at Princess Margaret Cancer Centre between 1995 and 2010. YA (n = 61) and those 40-65 (n = 366) were compared with regards to clinical stage at diagnosis, FL International Prognostic Index (FLIPI) score, and the following clinical

outcomes:

time to second treatment, cause-specific survival (CSS) and overall survival (OS). At diagnosis, stage and FLIPI score were similar, as were the proportion of patients requiring therapy (YA 75% versus older adults 71%). Median follow-up was 8.1 years. Time to second therapy was similar in both age groups (5-year probability 23% YA versus 27% older adults; Gray's P-value = 0.76). Ten-year OS was significantly higher for YA (87% versus older adults 72%; P = 0.029). On multivariate analysis, age <40 years, low FLIPI score and observation as initial management were favourable prognostic factors for OS and CSS. We conclude that YA with FL have a favourable prognosis compared to older patients; whether this reflects competing mortality risks or age-related differences in lymphoma biology warrants further investigation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bases de Dados Factuais / Linfoma Folicular Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bases de Dados Factuais / Linfoma Folicular Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Canadá